People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Pharma, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prometheus Therapeutics Inc. | — | Pharma | Series A | $8.9M | $370K | 2020 |
| Deinde Medical Corp. | — | Healthtech | Seed | $6.5M | $472K | 2019 |
| NeuroFine Corp. | — | Other Health Care | Seed | $3.3M | $341K | 2021 |
| InNeuroCo, Inc. | — | Other Health Care | Pre-Seed | $2.3M | $24.7M | 2014 |
Ajay Wakhloo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ajay Wakhloo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John McEleney | 4 | 6 |
| Marc Litzenberg | 4 | 5 |
| Bernie Navarro | 3 | 3 |
| Bernardo Navarro | 2 | 2 |
| Prattipati Laxminarain | 1 | 3 |
| Baruch Lieber | 1 | 1 |
| Daniel Sablyak | 1 | 1 |
| Dan Sablyak | 1 | 1 |
| Jennifer Halsey | 1 | 1 |
| Dan Sabylak | 1 | 1 |
| Alexander Hastings | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.